Literature DB >> 19969529

Identification of patients with nonmelanoma skin cancer using health maintenance organization claims data.

Melody J Eide1, Richard Krajenta, Dayna Johnson, Jordan J Long, Gordon Jacobsen, Maryam M Asgari, Henry W Lim, Christine C Johnson.   

Abstract

Cancer registries usually exclude nonmelanoma skin cancers (NMSC), despite the large population affected. Health maintenance organization (HMO) and health system administrative databases could be used as sampling frames for ascertaining NMSC. NMSC patients diagnosed between January 1, 1988, and December 31, 2007, from such defined US populations were identified by using 3 algorithms: NMSC International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, NMSC treatment Current Procedural Terminology (CPT) codes, or both codes. A subset of charts was reviewed to verify NMSC diagnosis, including all records from HMO-enrollee members in 2007. Positive predictive values for NMSC ascertainment were calculated. Analyses of data from 1988-2007 ascertained 11,742 NMSC patients. A random sample of 965 cases was selected for chart review, and NMSCs were validated in 47.0% of ICD-9-CM-identified patients, 73.4% of CPT-identified patients, and 94.9% identified with both codes. All charts from HMO-health plan enrollees in 2007 were reviewed (n = 1,116). Cases of NMSC were confirmed in 96.5% of ICD-9-CM-identified patients, 98.3% of CPT-identified patients, and 98.7% identified with both codes. HMO administrative data can be used to ascertain NMSC with high positive predictive values with either ICD-9-CM or CPT code, but both codes may be necessary among non-HMO patient populations.

Entities:  

Mesh:

Year:  2009        PMID: 19969529      PMCID: PMC2796985          DOI: 10.1093/aje/kwp352

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  21 in total

1.  Nonmelanoma skin cancer: is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data.

Authors:  Mary-Margaret Bivens; Monali Bhosle; Rajesh Balkrishnan; Fabian T Camacho; Steven R Feldman; Alan B Fleischer
Journal:  Dermatol Surg       Date:  2006-12       Impact factor: 3.398

2.  Building a virtual cancer research organization.

Authors:  Mark C Hornbrook; Gene Hart; Jennifer L Ellis; Donald J Bachman; Gary Ansell; Sarah M Greene; Edward H Wagner; Roy Pardee; Mark M Schmidt; Ann Geiger; Amy L Butani; Terry Field; Hassan Fouayzi; Irina Miroshnik; Liyan Liu; Robert Diseker; Karen Wells; Rick Krajenta; Lois Lamerato; Christine Neslund Dudas
Journal:  J Natl Cancer Inst Monogr       Date:  2005

3.  The sensitivity of Medicare claims data for case ascertainment of six common cancers.

Authors:  G S Cooper; Z Yuan; K C Stange; L K Dennis; S B Amini; A A Rimm
Journal:  Med Care       Date:  1999-05       Impact factor: 2.983

4.  Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.

Authors:  I Marcil; R S Stern
Journal:  Arch Dermatol       Date:  2000-12

5.  The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology.

Authors:  David R Bickers; Henry W Lim; David Margolis; Martin A Weinstock; Clifford Goodman; Eric Faulkner; Ciara Gould; Eric Gemmen; Tim Dall
Journal:  J Am Acad Dermatol       Date:  2006-09       Impact factor: 11.527

6.  An algorithm for the use of Medicare claims data to identify women with incident breast cancer.

Authors:  Ann B Nattinger; Purushottam W Laud; Ruta Bajorunaite; Rodney A Sparapani; Jean L Freeman
Journal:  Health Serv Res       Date:  2004-12       Impact factor: 3.402

7.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

8.  Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.

Authors:  Heather T Gold; Huong T Do
Journal:  Health Serv Res       Date:  2007-10       Impact factor: 3.402

9.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

10.  A high positive predictive value algorithm using hospital administrative data identified incident cancer cases.

Authors:  Ileana Baldi; Piera Vicari; Daniela Di Cuonzo; Roberto Zanetti; Eva Pagano; Rosalba Rosato; Carlotta Sacerdote; Nereo Segnan; Franco Merletti; Giovannino Ciccone
Journal:  J Clin Epidemiol       Date:  2007-10-22       Impact factor: 6.437

View more
  15 in total

1.  Trends in health-related quality of life of female breast cancer survivors using the Medical Expenditure Panel Survey (MEPS), 2008-2016.

Authors:  Inimfon Jackson; Paul Rowan; Nikhil Padhye; Lu-Yu Hwang; Sally W Vernon
Journal:  Qual Life Res       Date:  2021-05-29       Impact factor: 4.147

2.  Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing.

Authors:  Jason P Lott; Denise M Boudreau; Ray L Barnhill; Martin A Weinstock; Eleanor Knopp; Michael W Piepkorn; David E Elder; Steven R Knezevich; Andrew Baer; Anna N A Tosteson; Joann G Elmore
Journal:  JAMA Dermatol       Date:  2018-01-01       Impact factor: 10.282

3.  Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.

Authors:  Efe Eworuke; Nicole Haug; Marie Bradley; Austin Cosgrove; Tancy Zhang; Elizabeth C Dee; Sruthi Adimadhyam; Andrew Petrone; Hana Lee; Tiffany Woodworth; Sengwee Toh
Journal:  JNCI Cancer Spectr       Date:  2021-02-04

4.  Validation of claims data algorithms to identify nonmelanoma skin cancer.

Authors:  Melody J Eide; J Mark Tuthill; Richard J Krajenta; Gordon R Jacobsen; Marc Levine; Christine C Johnson
Journal:  J Invest Dermatol       Date:  2012-04-05       Impact factor: 8.551

Review 5.  Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches.

Authors:  Zoe Apalla; Dorothée Nashan; Richard B Weller; Xavier Castellsagué
Journal:  Dermatol Ther (Heidelb)       Date:  2017-02-01

6.  Evaluating the trend of cutaneous malignant tumors in Ilam from 2002 to 2011.

Authors:  Mohammad R Hafezi Ahmadi; Zeinab Bakhtari; Behrang Kazeminezhad; Samiramis Ghavam
Journal:  J Family Med Prim Care       Date:  2019-02

7.  The role of immunohistochemistry expression of COX-2 in differentiating pigmented benign and malignant skin neoplasms.

Authors:  Maryam Ghasemi; Parvaneh Afshar; Somayeh Sheidaei; Yosef Moeini; Lale Vahedi Larijani
Journal:  Med J Islam Repub Iran       Date:  2019-07-25

8.  The Epidemiology of Skin Cancer and its Trend in Iran.

Authors:  Saeid Razi; Mostafa Enayatrad; Abdollah Mohammadian-Hafshejani; Hamid Salehiniya; Mehri Fathali-Loy-Dizaji; Shahin Soltani
Journal:  Int J Prev Med       Date:  2015-07-16

9.  Epidemiological trends in skin cancer.

Authors:  Zoe Apalla; Aimilios Lallas; Elena Sotiriou; Elizabeth Lazaridou; Demetrios Ioannides
Journal:  Dermatol Pract Concept       Date:  2017-04-30

10.  The incidence and clinical analysis of non-melanoma skin cancer.

Authors:  Magdalena Ciążyńska; Grażyna Kamińska-Winciorek; Dariusz Lange; Bogumił Lewandowski; Adam Reich; Martyna Sławińska; Marta Pabianek; Katarzyna Szczepaniak; Adam Hankiewicz; Małgorzata Ułańska; Jan Morawiec; Maria Błasińska-Morawiec; Zbigniew Morawiec; Janusz Piekarski; Dariusz Nejc; Robert Brodowski; Anna Zaryczańska; Michał Sobjanek; Roman J Nowicki; Witold Owczarek; Monika Słowińska; Katarzyna Wróbel; Andrzej Bieniek; Anna Woźniacka; Małgorzata Skibińska; Joanna Narbutt; Wojciech Niemczyk; Karol Ciążyński; Aleksandra Lesiak
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.